ADCS Prevention Instrument Project: ADCS-Clinicians' Global Impression of Change scales (ADCS-CGIC), self-rated and study partner-rated versions

Alzheimer Disease and Associated Disorders

Volumn 20, Issue SUPPL. 3, 2006, Pages

  Schneider, Lon S ^a   Clark, Christopher M ^b   Doody, Rachelle ^c   Ferris, Steven H ^d   Morris, John C ^e   Raman, Rema ^f   Reisberg, Barry ^d   Schmitt, Frederick A ^g  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer disease; Cognitive screening; Delayed recall; Memory assessment

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL DEMENTIA RATING SCALE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DCS CLINICIAN GLOBAL IMPRESSION OF CHANGE SCALE; DISEASE SEVERITY; FEMALE; HOME CARE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEMORY; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECALL; RELIABILITY; SCORING SYSTEM; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; SIMULATION; STATISTICAL ANALYSIS; VALIDATION PROCESS; VALIDITY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMBULATORY CARE FACILITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PRIMARY PREVENTION; PROXY; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF ASSESSMENT (PSYCHOLOGY); SOCIAL BEHAVIOR;

EID: 33845463118     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000213878.47924.44     Document Type: Article

References (16)

1. Ferris SH, Aisen PS, Cummings J, et al., the Alzheimer's Disease Cooperative Study Group. ADCS Prevention Instrument Project: overview and initial results. Alzheimer Dis Assoc Disord. 2006;20(supp 7):S109-S123.
2. Leber P. Guidelines for the Clinical Evaiuation of Anti-dementia Drugs, 1st Draft. Rockville: US Food and Drug Administration; 1990. Unpublished.
3. Teng EL, Chui HC. The modified mini mental state (3MS) examination. J Clin Psychiatry. 1987;48:314-318.
4. Grober E, Buschke H, Crystal H, et al. Screening for dementia by memory testing. Neurology. 1988;38:900-903.
5. Galasko D, Bennett DA, Sano M, et al., the ADCS Study Group. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord. 2006;20(supp 7):S152-S169.
6. Salmon DP, Cummings JL, Jin S, et al., the Alzheimer's Disease Cooperative Study. ADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials. Alzheimer Dis Assoc Disord. 2006;20(supp 7):S139-S146.
7. Cummings JL, Raman R, Ernstrom K, et al., the Alzheimer's Disease Cooperative Study Group. ADCS Prevention Instrument Project: behavioral measures in primary prevention trials. Alzheimer Dis Assoc Disord. 2006;20(supp 7):S147-S151.
8. Patterson MB, Whitehouse PJ, Edland SD, et al., the Alzheimer's Disease Cooperative Study Group. ADCS Prevention Instrument Project: quality of life (QOL) assessment. Alzheimer Dis Assoc Disord. 2006;20(supp 7):S179-S190.
9. Sano M, Zhu C, Whitehouse P, et al., the Alzheimer's Disease Cooperative Study Group. ADCS Prevention Instrument Project: pharmacoeconomics - assessing health related resource use among healthy elderly. Alzheimer Dis Assoc Disord. 2006;20(supp 7):S191-S202.
10. Walsh S, Raman R, Jones K, et al., for the Alzheimer's Disease Cooperative Study Group. ADCS Prevention Instrument Project: the mail-in cognitive function screening instrument (MCFSI). Alzheimer Dis Assoc Disord. 2006;20(supp 7):S170-S178.
11. Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
12. Shoukri MM. Measures of Interobserver Agreement. Boca Raton, Florida: CRC Press; 2003.
13. Feinstein AR, Cincchetti DV. High agreement but low Kappa: the problems of two paradoxes. J Clin Epidemiol. 1990;43:543-549.
14. Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa. J Clin Epidemiol. 1993;46:423-429.
15. Schneider LS, Olin JT, Doody RS, et al., the Alzheimer's Disease Cooperative Study. Validity and reliability of the Alzheimer's disease cooperative study-clinical global impression of change. Alzheimer Dis Assoc Disord. 1997;11(suppl 2):S22-S32.
16. Carr D, Gray S, Baty J, et al. The value of informant vs individual's complaints of memory impairment in early dementia. Neurology. 2000;55:1724-1726.